Process
Development

Optimized Process Development
for Cell & Gene Therapies

Service
Description

At CCS, we specialize in Process Development for cell and gene therapy, helping biotechnology and pharmaceutical companies optimize their cell-based therapies from early development to large-scale production. Our comprehensive approach combines cutting-edge technologies, CMC expertise, and a commitment to quality, ensuring your therapies reach the clinic and market efficiently. 

Why
Choose us?

Service
Offerings

Initial Consultation & Feasibility Assessment

We evaluate your therapeutic product’s needs, assess process development strategies, and identify potential risks for optimal manufacturing outcomes.

Process Analytics

We implement robust testing plans for starting material characterization, in-process testing, product characterization, and final product quality control.

Process Development

We design reproducible protocols for cell isolation, expansion, and differentiation, ensuring high-quality product output across various cell types.

Tech Transfer

We ensure a seamless transition from R&D to GMP manufacturing, maintaining quality, yield, and consistency while implementing necessary documentation and protocols.

CMC Consulting Support

Our experts help streamline operations, mitigate risks, and ensure regulatory readiness, from early development to clinical trials and late-stage development.

Process Optimization

We refine protocols, raw materials, and automation to maximize yields, enhance efficiency, and ensure scalable production.

Scale-Up

We facilitate the transition from early-phase production to large-scale manufacturing, ensuring efficiency, cost-effectiveness, and GMP compliance at every stage.

You may also be interested in:

Adopting Modular, Semi-Automated Approaches to Optimize Process and Analytical Development for CGT

Streamlining Advanced Therapy Tech Transfer: Balancing Early-Stage Needs with Future Success